vs

Side-by-side financial comparison of DYCOM INDUSTRIES INC (DY) and Edwards Lifesciences (EW). Click either name above to swap in a different company.

Edwards Lifesciences is the larger business by last-quarter revenue ($1.6B vs $1.5B, roughly 1.1× DYCOM INDUSTRIES INC). Edwards Lifesciences runs the higher net margin — 23.1% vs 7.3%, a 15.8% gap on every dollar of revenue. On growth, Edwards Lifesciences posted the faster year-over-year revenue change (16.7% vs 14.1%). Over the past eight quarters, DYCOM INDUSTRIES INC's revenue compounded faster (23.5% CAGR vs 9.7%).

Quanta Services is a U.S. corporation that provides infrastructure services for the electric power, pipeline, industrial and communications industries. Its capabilities include planning, design, installation, program management, maintenance and repair of most types of network infrastructure. The company has grown organically since its founding, but it has also acquired over 150 companies in the electrical contracting industry. It has provided its services and expertise to many major electrica...

Edwards Lifesciences Corporation is an American medical technology company headquartered in Irvine, California, specializing in artificial heart valves and hemodynamic monitoring. It developed the Sapien transcatheter aortic heart valve made of cow tissue within a balloon-expandable, cobalt-chromium frame, deployed via catheter.

DY vs EW — Head-to-Head

Bigger by revenue
EW
EW
1.1× larger
EW
$1.6B
$1.5B
DY
Growing faster (revenue YoY)
EW
EW
+2.6% gap
EW
16.7%
14.1%
DY
Higher net margin
EW
EW
15.8% more per $
EW
23.1%
7.3%
DY
Faster 2-yr revenue CAGR
DY
DY
Annualised
DY
23.5%
9.7%
EW

Income Statement — Q3 FY2026 vs Q1 FY2026

Metric
DY
DY
EW
EW
Revenue
$1.5B
$1.6B
Net Profit
$106.4M
$380.7M
Gross Margin
78.0%
Operating Margin
9.7%
1.8%
Net Margin
7.3%
23.1%
Revenue YoY
14.1%
16.7%
Net Profit YoY
52.4%
6.8%
EPS (diluted)
$3.63
$0.66

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
DY
DY
EW
EW
Q1 26
$1.6B
Q4 25
$1.5B
$1.6B
Q3 25
$1.4B
$1.6B
Q2 25
$1.3B
$1.5B
Q1 25
$1.1B
$1.4B
Q4 24
$1.3B
$1.4B
Q3 24
$1.2B
$1.4B
Q2 24
$1.1B
$1.4B
Net Profit
DY
DY
EW
EW
Q1 26
$380.7M
Q4 25
$106.4M
$91.2M
Q3 25
$97.5M
$291.1M
Q2 25
$61.0M
$333.2M
Q1 25
$32.7M
$358.0M
Q4 24
$69.8M
$385.6M
Q3 24
$68.4M
$3.1B
Q2 24
$62.6M
$366.3M
Gross Margin
DY
DY
EW
EW
Q1 26
78.0%
Q4 25
78.1%
Q3 25
77.8%
Q2 25
77.5%
Q1 25
78.7%
Q4 24
78.9%
Q3 24
80.6%
Q2 24
79.9%
Operating Margin
DY
DY
EW
EW
Q1 26
1.8%
Q4 25
9.7%
9.6%
Q3 25
9.5%
19.8%
Q2 25
6.2%
26.8%
Q1 25
4.1%
27.9%
Q4 24
7.2%
22.6%
Q3 24
7.9%
25.9%
Q2 24
6.8%
26.8%
Net Margin
DY
DY
EW
EW
Q1 26
23.1%
Q4 25
7.3%
5.8%
Q3 25
7.1%
18.7%
Q2 25
4.9%
21.7%
Q1 25
3.0%
25.3%
Q4 24
5.5%
27.8%
Q3 24
5.7%
226.7%
Q2 24
5.5%
26.7%
EPS (diluted)
DY
DY
EW
EW
Q1 26
$0.66
Q4 25
$3.63
$0.16
Q3 25
$3.33
$0.50
Q2 25
$2.09
$0.56
Q1 25
$1.11
$0.61
Q4 24
$2.37
$0.65
Q3 24
$2.32
$5.13
Q2 24
$2.12
$0.61

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
DY
DY
EW
EW
Cash + ST InvestmentsLiquidity on hand
$110.1M
Total DebtLower is stronger
Stockholders' EquityBook value
$1.5B
Total Assets
$3.3B
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
DY
DY
EW
EW
Q1 26
Q4 25
$110.1M
$4.2B
Q3 25
$28.5M
$3.8B
Q2 25
$16.1M
$4.1B
Q1 25
$92.7M
$3.9B
Q4 24
$15.3M
$4.0B
Q3 24
$19.6M
$4.4B
Q2 24
$26.1M
$2.0B
Stockholders' Equity
DY
DY
EW
EW
Q1 26
Q4 25
$1.5B
$10.3B
Q3 25
$1.4B
$10.2B
Q2 25
$1.3B
$10.5B
Q1 25
$1.2B
$10.1B
Q4 24
$1.2B
$10.0B
Q3 24
$1.2B
$9.5B
Q2 24
$1.1B
$7.4B
Total Assets
DY
DY
EW
EW
Q1 26
Q4 25
$3.3B
$13.7B
Q3 25
$3.2B
$13.3B
Q2 25
$3.1B
$13.5B
Q1 25
$2.9B
$13.0B
Q4 24
$3.1B
$13.1B
Q3 24
$2.8B
$13.0B
Q2 24
$2.6B
$10.1B

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
DY
DY
EW
EW
Operating Cash FlowLast quarter
$220.0M
Free Cash FlowOCF − Capex
$164.8M
FCF MarginFCF / Revenue
11.4%
Capex IntensityCapex / Revenue
3.8%
Cash ConversionOCF / Net Profit
2.07×
TTM Free Cash FlowTrailing 4 quarters
$296.8M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
DY
DY
EW
EW
Q1 26
Q4 25
$220.0M
$450.9M
Q3 25
$57.4M
$573.7M
Q2 25
$-54.0M
$290.2M
Q1 25
$328.2M
$280.4M
Q4 24
$65.8M
$-127.5M
Q3 24
$-7.5M
$351.8M
Q2 24
$-37.4M
$371.5M
Free Cash Flow
DY
DY
EW
EW
Q1 26
Q4 25
$164.8M
$353.5M
Q3 25
$5.8M
$516.2M
Q2 25
$-133.5M
$240.9M
Q1 25
$259.7M
$224.4M
Q4 24
$-8.8M
$-177.3M
Q3 24
$-72.9M
$299.9M
Q2 24
$-79.4M
$286.1M
FCF Margin
DY
DY
EW
EW
Q1 26
Q4 25
11.4%
22.5%
Q3 25
0.4%
33.2%
Q2 25
-10.6%
15.7%
Q1 25
23.9%
15.9%
Q4 24
-0.7%
-12.8%
Q3 24
-6.1%
22.1%
Q2 24
-6.9%
20.9%
Capex Intensity
DY
DY
EW
EW
Q1 26
Q4 25
3.8%
6.2%
Q3 25
3.8%
3.7%
Q2 25
6.3%
3.2%
Q1 25
6.3%
4.0%
Q4 24
5.9%
3.6%
Q3 24
5.4%
3.8%
Q2 24
3.7%
6.2%
Cash Conversion
DY
DY
EW
EW
Q1 26
Q4 25
2.07×
4.94×
Q3 25
0.59×
1.97×
Q2 25
-0.88×
0.87×
Q1 25
10.05×
0.78×
Q4 24
0.94×
-0.33×
Q3 24
-0.11×
0.11×
Q2 24
-0.60×
1.01×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons